ECR Pharmaceuticals (Amrix Product Line) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

ECR Pharmaceuticals (Amrix Product Line) General Information

Description

North American rights to formulate AMRIX. The drug is used as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute musculoskeletal conditions.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Corporate Office
  • P.O. Box 71600
  • Richmond, VA 23255
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ECR Pharmaceuticals (Amrix Product Line) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ECR Pharmaceuticals (Amrix Product Line)‘s full profile, request access.

Request a free trial

ECR Pharmaceuticals (Amrix Product Line) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore ECR Pharmaceuticals (Amrix Product Line)‘s full profile, request access.

Request a free trial

ECR Pharmaceuticals (Amrix Product Line) FAQs

  • Where is ECR Pharmaceuticals (Amrix Product Line) headquartered?

    ECR Pharmaceuticals (Amrix Product Line) is headquartered in Richmond, VA.

  • What industry is ECR Pharmaceuticals (Amrix Product Line) in?

    ECR Pharmaceuticals (Amrix Product Line)’s primary industry is Buildings and Property.

  • Is ECR Pharmaceuticals (Amrix Product Line) a private or public company?

    ECR Pharmaceuticals (Amrix Product Line) is a Private company.

  • What is the current valuation of ECR Pharmaceuticals (Amrix Product Line)?

    The current valuation of ECR Pharmaceuticals (Amrix Product Line) is 00000.

  • What is ECR Pharmaceuticals (Amrix Product Line)’s current revenue?

    The current revenue for ECR Pharmaceuticals (Amrix Product Line) is 000000.

  • Who are ECR Pharmaceuticals (Amrix Product Line)’s investors?

    E. Claiborne Robins Co. has invested in ECR Pharmaceuticals (Amrix Product Line).

  • When was ECR Pharmaceuticals (Amrix Product Line) acquired?

    ECR Pharmaceuticals (Amrix Product Line) was acquired on 28-Aug-2007.

  • Who acquired ECR Pharmaceuticals (Amrix Product Line)?

    ECR Pharmaceuticals (Amrix Product Line) was acquired by Cephalon.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »